Neurogenic stunned myocardium (NSM) is a triad of transient left ventricular dysfunction, electrocardiogram changes, and elevation in cardiac enzymes, often mimicking a myocardial infarction. It has been described following acute brain injury. The purported mechanism is catecholamine excess resulting in cardiac dysfunction. From the clinical standpoint, the most frequently encountered electrocardiographic changes are QTc prolongation and ST-T changes, with modest elevations in troponin levels. Basal and mid-ventricular segments of the left ventricle are most commonly involved. NSM poses therapeutic challenges when it occurs secondary to aneurysmal subarachnoid hemorrhage, particularly in the setting of coexisting vasospasm. Overall, NSM carries good prognosis if recognized early, with appropriate management of hemodynamic and cardiopulmonary parameters.
PilgrimTMWyssTR. Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol. 2008;124(3):283–292.
2.
CebelinMSHirschCS. Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Pathol. 1980;11(2):123–132.
3.
AkashiYJNefHMMollmannHUeyamaT. Stress cardiomyopathy. Ann Rev Med. 2010;61:271–286.
4.
TsuchihashiKUeshimaKUchidaT. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. angina pectoris-myocardial infarction investigations in Japan. J Am Coll Cardiol. 2001;38(1):11–18.
5.
KawaiSSuzukiHYamaguchiH. Ampulla cardiomyopathy (‘Takotusbo’ cardiomyopathy)—reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J. 2000;64(2):156–159.
6.
BrandspiegelHZMarinchakRARialsSJKoweyPR. A broken heart. Circulation. 1998;98(13):1349.
7.
AkashiYJNakazawaKSakakibaraMMiyakeFKoikeHSasakaK. The clinical features of Takotsubo cardiomyopathy. QJM. 2003;96(8):563–573.
8.
MadhavanMPrasadA. Proposed Mayo clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis. Herz. 2010;35(4):240–243.
9.
KonoTMoritaHKuroiwaTOnakaHTakatsukaHFujiwaraA. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24(3):636–640.
10.
SugimotoKWatanabeEYamadaA. Prognostic implications of left ventricular wall motion abnormalities associated with subarachnoid hemorrhage. Int Heart J. 2008;49(1):75–85.
11.
TanabeMCragoEASuffolettoMS. Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol. 2008;102(11):1545–1550.
12.
HravnakMFrangiskakisJMCragoEA. Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke. 2009;40(11):3478–3484.
13.
BankiNKopelnikATungP. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg. 2006;105(1):15–20.
14.
DeiningerMHRadickeDButtlerJScheuflerKMFreimanTZentnerJF. Tako-Tsubo cardiomyopathy: reversible heart failure with favorable outcome in patients with intracerebral hemorrhage. Case report. J Neurosurg. 2006;105(3):465–467.
15.
YoshimuraSToyodaKOharaT. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol. 2008;64(5):547–554.
16.
DupuisMvan RijckevorselKEvrardFDubuissonNDupuisFVan RobaysP. Takotsubo syndrome (TKS): a possible mechanism of sudden unexplained death in epilepsy (SUDEP). Seizure. 2012;21(1):51–54.
17.
BernsteinRMayerSAMagnanoA. Neurogenic stunned myocardium in Guillain-Barre syndrome. Neurology. 2000;54(3):759–762.
18.
RieraMLlompart-PouJACarrilloABlancoC. Head injury and inverted Takotsubo cardiomyopathy. J Trauma. 2010;68(1):E13–E15.
LeeVHOhJKMulvaghSLWijdicksEF. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243–249.
22.
BenarrochEE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993;68(10):988–1001.
23.
LoewyAD. Descending pathways to the sympathetic preganglionic neurons. Prog Brain Res. 1982;57:267–277.
24.
OppenheimerSMCechettoDF. Cardiac chronotropic organization of the rat insular cortex. Brain Res. 1990;533(1):66–72.
25.
OppenheimerS. Cerebrogenic cardiac arrhythmias: cortical lateralization and clinical significance. Clin Auton Res. 2006;16(1):6–11.
26.
MelvilleKIBlumBShisterHESilverMD. Cardiac ischemic changes and arrhythmias induced by hypothalamic stimulation. Am J Cardiol. 1963;12:781–791.
27.
JeanA. The nucleus tractus solitarius: neuroanatomic, neurochemical and functional aspects [in French]. Arch Int Physiol Biochim Biophys. 1991;99(5):A3–A52.
28.
MorrisonSF. RVLM and raphe differentially regulate sympathetic outflows to splanchnic and brown adipose tissue. Am J Physiol. 1999;276(4 pt 2):R962–R973.
29.
DoshiRNeil-DwyerG. Hypothalamic and myocardial lesions after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1977;40(8):821–826.
30.
ConnorRC. Myocardial damage secondary to brain lesions. Am Heart J. 1969;78(2):145–148.
31.
JacobWAVan BogaertADe Groodt-LasseelMH. Myocardial ultrastructure and haemodynamic reactions during experimental subarachnoid haemorrhage. J Mol Cell Cardiol. 1972;4(4):287–298.
32.
MasudaTSatoKYamamotoS. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke. 2002;33(6):1671–1676.
33.
WittsteinISThiemannDRLimaJA. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548.
34.
HawkinsWEClowerBR. Myocardial damage after head trauma and simulated intracranial haemorrhage in mice: the role of the autonomic nervous system. Cardiovasc Res. 1971;5(4):524–529.
AkashiYJGoldsteinDSBarbaroGUeyamaT. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118(25):2754–2762.
38.
UeyamaTYoshidaKSenbaE. Emotional stress induces immediate-early gene expression in rat heart via activation of alpha- and beta-adrenoceptors. Am J Physiol. 1999;277(4 pt 2):H1553–H1561.
39.
PortJDBristowMR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol. 2001;33(5):887–905.
40.
HeubachJFRavensUKaumannAJ. Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol. 2004;65(5):1313–1322.
41.
HeubachJFBlaschkeMHardingSERavensUKaumannAJ. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 2003;367(4):380–390.
42.
KawanoHOkadaRYanoK. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels. 2003;18(1):32–39.
43.
NefHMMollmannHHilpertP. Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy. Eur J Heart Fail. 2009;11(8):758–764.
44.
BurchGEMeyersRAbildskovJA. A new electrocardiographic pattern observed in cerebrovascular accidents. Circulation. 1954;9(5):719–723.
45.
BrouwersPJWijdicksEFHasanD. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke. 1989;20(9):1162–1167.
46.
SommargrenCEZaroffJGBankiNDrewBJ. Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J Electrocardiol. 2002;35suppl:257–262.
47.
SalvatiMCosentinoFArticoM. Electrocardiographic changes in subarachnoid hemorrhage secondary to cerebral aneurysm. Report of 70 cases. Ital J Neurol Sci. 1992;13(5):409–413.
48.
ZaroffJGRordorfGAOgilvyCSPicardMH. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000;13(8):774–779.
49.
MayerSALiMandriGShermanD. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg. 1995;83(5):889–896.
50.
DibCAsirvathamSElesberARihalCFriedmanPPrasadA. Clinical correlates and prognostic significance of electrocardiographic abnormalities in apical ballooning syndrome (Takotsubo/stress-induced cardiomyopathy). Am Heart J. 2009;157(5):933–938.
51.
FronteraJAParraAShimboD. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis. 2008;26(1):71–78.
52.
FrangiskakisJMHravnakMCragoEA. Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care. 2009;10(3):287–294.
53.
SakrYLLimNAmaralAC. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2004;96(3):369–373.
54.
SchuilingWJAlgraAde WeerdAWLeemansPRinkelGJ. ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage. Acta Neurochir (Wien). 2006;148(8):853–858; discussion 858.
55.
SamuelsMA. The brain–heart connection. Circulation. 2007;116(1):77–84.
56.
TungPPOlmstedEKopelnikA. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36(7):1567–1569.
57.
BulsaraKRMcGirtMJLiaoL. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(3):524–528.
58.
NaidechAMKreiterKTJanjuaN. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851–2856.
59.
ParekhNVenkateshBCrossD. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36(4):1328–1335.
60.
TungPKopelnikABankiN. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35(2):548–551.
61.
DeibertEBarzilaiBBravermanAC. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg. 2003;98(4):741–746.
62.
KopelnikAFisherLMissJC. Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care. 2005;3(2):132–138.
63.
KhushKKopelnikATungP. Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr. 2005;18(2):168–174.
BrunettiNDIevaRRossiG. Ventricular outflow tract obstruction, systolic anterior motion and acute mitral regurgitation in Tako-Tsubo syndrome. Int J Cardiol. 2008;127(3):e152–e157.
66.
BurriMVNandaNCLloydSG. Assessment of systolic and diastolic left ventricular and left atrial function using vector velocity imaging in Takotsubo cardiomyopathy. Echocardiogr. 2008;25(10):1138–1144.
67.
MansencalNAbbouNPilliereREl MahmoudRFarcotJCDubourgO. Usefulness of two-dimensional speckle tracking echocardiography for assessment of Tako-Tsubo cardiomyopathy. Am J Cardiol. 2009;103(7):1020–1024.
68.
MayerSAFinkMEHommaS. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology. 1994;44(5):815–820.
69.
DiringerMNBleckTPClaude HemphillJIII. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's multidisciplinary consensus conference. Neurocrit Care. 2011;15(2):211–240.
70.
PollickCCujecBParkerSTatorC. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol. 1988;12(3):600–605.
71.
BruderNRabinsteinA, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H. Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):257–269.
72.
de ChazalIParhamWMIIILiopyrisPWijdicksEF. Delayed cardiogenic shock and acute lung injury after aneurysmal subarachnoid hemorrhage. Anesth Analg. 2005;100(4):1147–1149.
73.
ChangPCLeeSHHungHFKaunPChengJJ. Transient ST elevation and left ventricular asynergy associated with normal coronary artery and Tc-99m PYP Myocardial Infarct Scan in subarachnoid hemorrhage. Int J Cardiol. 1998;63(2):189–192.
74.
HessEPBoieETWhiteRD. Survival of a neurologically intact patient with subarachnoid hemorrhage and cardiopulmonary arrest. Mayo Clin Proc. 2005;80(8):1073–1076.
75.
CruickshankJMNeil-DwyerGLaneJ. The effect of oral propranolol upon the ECG changes occurring in subarachnoid haemorrhage. Cardiovasc Res. 1975;9(2):236–245.
76.
Neil-DwyerGWalterPCruickshankJMDoshiBO'GormanP. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978;2(6143):990–992.
77.
Neil-DwyerGWalterPCruickshankJM. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol. 1985;28suppl:25–29.
78.
WalterPNeil-DwyerGCruickshankJM. Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. Br Med J (Clin Res Ed). 1982;284(6330):1661–1664.
79.
NaidechADuYKreiterKT. Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery. 2005;56(1):21–26.
80.
BusaniSRinaldiLSeverinoCCobelliMPasettoAGirardisM. Levosimendan in cardiac failure after subarachnoid hemorrhage. J Trauma. 2010;68(5):E108–E110.
81.
MoiseyevVSPoderPAndrejevsN. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. a randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002;23(18):1422–1432.
82.
EllgerBMZahnPKVan AkenHKSchmidtCBrusselT. Levosimendan: a promising treatment for myocardial stunning?Anaesthesia. 2006;61(1):61–63.
ApostolidesPJGreeneKAZabramskiJMFitzgeraldJWSpetzlerRF. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery. 1996;38(5):1056–1059; discussion 1059-1060.
86.
NussbaumESSebringLAGanzWFMadisonMT. Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study. Neurosurgery. 1998;42(1):206–213.
87.
LazaridisCPradillaGNyquistPATamargoRJ. Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. case report and review of the literature. Neurocrit Care. 2010;13(1):101–108.
88.
WijdicksEFVermeulenMten HaafJAHijdraABakkerWHvan GijnJ. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol. 1985;18(2):211–216.
89.
SolomonRAPostKDMcMurtryJGIII. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery. 1984;15(3):354–361.
90.
FriedmanJAPichelmannMAPiepgrasDG. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52(5):1025–1031.
91.
MayerSALinJHommaS. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30(4):780–786.
92.
JyotsnaMPrasadVIndraniGTrikamjiBV. Importance of detection of segmental wall motion abnormalities of left ventricle in nontraumatic subarachnoid hemorrhage: a prospective study. Echocardiography. 2010;27(5):496–500.
93.
SongBGHahnJYChoSJ. Clinical characteristics, ballooning pattern, and long-term prognosis of transient left ventricular ballooning syndrome. Heart Lung. 2010;39(3):188–195.
